UPMC and Pitt Neurology at AAN 2026

UPMC and University of Pittsburgh Department of Neurology faculty, residents, fellows, and medical students will participate in a number of presentations, lectures, and clinics at the American Academy of Neurology annual meeting scheduled for April 18 to 22 in Chicago.

We also invite you to join us at our evening reception on Monday, April 20 from 7 to 9 p.m. RSVP here.

Below, we highlight each session featuring our distinguished faculty and department members:

• Autoimmune Neurology: Central Nervous System
  • Linnolia, Jenny, MD, PhD
• Mild Cognitive Impairment/Subjective Cognitive Impairment
  • Oscar L. Lopez, MD, FAAN
• Neurological Case Studies in Pregnancy
  • Eliza C. Miller, MD
• Critical Care Consultations for Neurohospitalists
  • Alexis M. Steinberg, MD
• Endovascular Management of Ischemic and Hemorrhagic Stroke
  • Cynthia L. Kenmuir, MD, PhD
• Epilepsy Therapy Update
  • Page B. Pennell, MD, FAAN
• From Idea to Influence: Building Advocacy Momentum (Practice & Policy H)
  • Joanna S. Fong-Isariyawongse, MD, FAAN
• Leading from the Middle: Building Leadership Identity, Alignment, and Strategic Growth from the Vice Chair Seat (Academic Hub)
  • Alexandra Urban, MD, FAAN
• It's Not Just a Man's World: Building a Women's Health Program
  • Mary A. O'Neal, MD, FAAN, Eliza C. Miller, MD, Wesley Kerr, MD, PhD
• CPT Showdown: Family Feud in the Coding Clinic
  • Alexandra Urban, MD, FAAN
• Building Trust, Driving Performance: Administrative Tools for Cultivating Leadership Culture
  • Alexandra Urban, MD, FAAN
• Epilepsy-related and All-cause Healthcare Resource Utilization After Initiation of Adjunctive Cenobamate
  • Wesley Kerr, MD, PhD
• Healthcare Resource Utilization, Antiseizure Medication Claims, and Treatment Persistence in Patients with Lennox-Gastaut Syndrome Receiving Fenfluramine in the United States
  • Wesley Kerr, MD, PhD
• Impact of a Brain Death Workshop on the Knowledge of Attendees
  • Lori A. Shutter, MD, FCCM, FNCS, FAAN
• Performance of the Neurological Pupil Index (NPi) in Predicting Neurologic Outcomes after Cardiac Arrest
  • Jonathan Elmer, MD
• Immune Checkpoint Inhibitor Induced Myasthenia Gravis-like Clinical Presentation: A Single Center Case Series
  • Gabriela Figueiredo Pucci, MD, Joshua Levenson, MD, Brendan L. McNeish, MD, David Lacomis, MD, FAAN, Fang Sun, MD, PhD
• Determinants of Late Cancellation and No-show Appointments Across General and Subspecialty Neurology Clinics     
  • Vijayalakshmi Rajasekaran, MD, FAAN, Kimberly Murin, Alexandra Urban, MD, FAAN
• An Approach to a Neurohumanities Elective for Medical Students
  • Cori Polonski, MD
• The Need for Triaging Papilledema Safely and Effectively: A Quality Improvement Survey
  • Mevish S. Siddiq, MD
• Mortality Risk After Initiation of Cenobamate or Other Antiseizure Medications
  • Wesley Kerr, MD, PhD
• Predicting the Timing of Cognitive Decline in Alzheimer’s Disease Using Real-world Clinical Data and Machine Learning
  • Zongqi Xia, MD, PhD
• Pediatrician Involvement in Communicating Positive Newborn Screening Results for Krabbe Disease: Barriers, Facilitators, and Ideas for Interventions
  • Laura A. Kirkpatrick, MD
• Ineligible by 1,000 Cuts: Identifying Epilepsy Clinical Trial Ineligibility from Structured Electronic Health Records
  • Wesley Kerr, MD, PhD
• Multiple Sclerosis Disease Activity is Uncommon in Individuals With Pre-existing Multiple Sclerosis Exposed to Immune Checkpoint Inhibitor Therapy
  • Andrew Morrison, MD, Sachin Gadani, MD, PhD, Jenny Linnoila, MD, PhD
• Semaphorin 4A (Sema4A) as a Biomarker for Demyelination in Multiple Sclerosis
  • Holly Appleberry, DO, MBA, Zongqi Xia, MD, PhD
• Simulations and Brain Death: A Novel Approach to Evaluating Competency
  • Lori A. Shutter, MD, FCCM, FNCS, FAAN
• Cobalamin Transporter Antibody-associated Ataxia and Longitudinal Posterior Column Myelopathy: A Diagnostic Challenge
  • Kaila R. Anderson, MD, Fellow, Sarah Berman, MD, Cigdem Isitan-Alkawadri, MD, Jenny Linnoila, MD, PhD
• Baseline EEG Abnormalities Predict Vulnerability to Postoperative Delirium: A Marker of Limited Cerebral Resilience Parthasarathy
  • Thirumala, MD, FAAN
• A Case Series of LMNB1-related Adult Onset Autosomal Dominant Adult Leukodystrophy (ADLD)
  • Holly Appleberry, DO, MBA
• Suspected Autoimmune Encephalitis in Hospitalized Adults: Diagnostic Yield and Predictors
  • Wesley Kerr, MD, PhD, Jenny Linnoila, MD, PhD
• Mortality Rates and Risk Factors Among Patients with Lennox-Gastaut Syndrome or Dravet Syndrome
  • Wesley Kerr, MD, PhD
• High Rates of Myasthenia Gravis Exacerbations in Individuals With Pre-existing Myasthenia Gravis Exposed to Immune Checkpoint Inhibitors
  • Andrew Morrison, MD, Jenny Linnoila, MD, PhD, Sachin Gadani, MD, PhD
• Updates on Muscle Disorders - 90-month Muscle Function and Biomarker Outcomes With Cipaglucosidase Alfa Plus Miglustat (Cipa+Mig) in Adults With Pompe Disease in ATB200-02, an Open-label Phase I/II Study
  • Paula R. Clemens, MD
• Health Equity in Pediatric Epilepsy Surgery: Barriers, Facilitators, and Ideas for Intervention
  • Laura A. Kirkpatrick, MD
• Section Showcase: Serving Up Specialty Curricula
  • Mary A. O'Neal, MD, FAAN